We are live on ! Find out more
ATXS

Astria Therapeutics
ATXS

Delisted

ATXS was delisted on the 22nd of January, 2026.

Back to rankings

0 hedge funds and large institutions have $0 invested in Astria Therapeutics in 2026 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 140 closing their positions.

New
Increased
Maintained
Reduced
Closed

99.02% less ownership

Funds ownership: 99.02% → 0% (-99%)

100% less funds holding

Funds holding: 141 → 0 (-141)

100% less capital invested

Capital invested by funds: $738M → $0 (-$738M)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 140

Holders
–
Holders Change
-141
Holders Change %
-100%
% of All Funds
–
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
140
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
PA
Perceptive Advisors
New York
-$84.9M
2
BlackRock
BlackRock
New York
-$50.2M
3
GCL
Glazer Capital LLC
New York
-$49.4M
4
MF
Magnetar Financial
Illinois
-$44.9M
5
UBS Group
UBS Group
Switzerland
-$31.4M
Name Holding Trade Value Shares
Change 		Change in
Stake
Jane Street
51
Jane Street
New York
– -$2.27M -173,511 Closed
VI
52
Vestcor Inc
New Brunswick, Canada
– -$2.19M -167,000 Closed
YCM
53
Yakira Capital Management
Connecticut
– -$2.04M -156,076 Closed
MS
54
Maven Securities
Jersey
– -$1.83M -139,578 Closed
Skandinaviska Enskilda Banken (SEB)
55
Skandinaviska Enskilda Banken (SEB)
Sweden
– -$1.7M -130,000 Closed
Bank of New York Mellon
56
Bank of New York Mellon
New York
– -$1.63M -124,164 Closed
QOP
57
Quinn Opportunity Partners
Virginia
– -$1.57M -120,000 Closed
Citadel Advisors
58
Citadel Advisors
Florida
– -$1.49M -113,555 Closed
Bank of Montreal
59
Bank of Montreal
Ontario, Canada
– -$1.46M -111,170 Closed
GLF
60
Groupe la Francaise
France
– -$1.42M -108,800 Closed
HF
61
HRT Financial
New York
– -$1.34M -102,453 Closed
Barclays
62
Barclays
United Kingdom
– -$1.31M -100,427 Closed
CIEC
63
Crédit Industriel et Commercial
France
– -$1.31M -100,000 Closed
N
64
Nuveen
North Carolina
– -$1.23M -93,961 Closed
American Century Companies
65
American Century Companies
Missouri
– -$1.11M -85,017 Closed
Bank of America
66
Bank of America
North Carolina
– -$1.09M -83,041 Closed
YIH
67
Y-Intercept (HK)
Hong Kong
– -$1.07M -81,501 Closed
TI
68
Tidal Investments
Wisconsin
– -$1.04M -79,201 Closed
N
69
Natixis
France
– -$916K -70,000 Closed
CL
70
CSS LLC
Illinois
– -$883K -67,422 Closed
RhumbLine Advisers
71
RhumbLine Advisers
Massachusetts
– -$829K -63,319 Closed
OAM
72
Oxford Asset Management
United Kingdom
– -$687K -52,517 Closed
ECM
73
ExodusPoint Capital Management
New York
– -$637K -48,636 Closed
AA
74
ALPS Advisors
Colorado
– -$614K -46,874 Closed
Wells Fargo
75
Wells Fargo
California
– -$613K -46,866 Closed
1 2
3
4 5

ATXS Hedge Fund Activity: Q1 2026 in Review

0 of the 8,130 institutional investors tracked by Wall St. Rank reported a position in Astria Therapeutics (ATXS) for Q1 2026, worth a combined $0 — down 100% from $738M a quarter earlier.

Sellers outnumbered buyers: 140 funds closed out of ATXS and 0 opened new positions — a net loss of 140 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was Perceptive Advisors, exiting entirely with an estimated $84.9M sold.

  • 0 institutional investors held Astria Therapeutics (ATXS) as of Q1 2026, down from 141 in Q4 2025.
  • Funds reported $0 of Astria Therapeutics stock for Q1 2026, down 100% quarter-over-quarter.
  • 0 funds opened new Astria Therapeutics positions in Q1 2026 and 140 closed out, a net change of -140 holders.
  • The largest Astria Therapeutics seller in Q1 2026 was Perceptive Advisors, an estimated $84.9M sold.

Based on aggregated 13F filings for Q1 2026.